Profile data is unavailable for this security.
About the company
Boundless Bio Inc, formerly Pretzel Therapeutics Inc, is a United States-based precision oncology company. The Company is focused on developing therapeutics directed against extrachromosomal DNA (ecDNA) to deliver transformative therapies to patients with previously intractable cancers.
- Revenue in USD (TTM)--
- Net income in USD--
- Incorporated2018
- Employees72.00
- LocationBoundless Bio Inc9880 Campus Point Drive, Suite 120SAN DIEGO 92121United StatesUSA
- Phone+1 (858) 766-9912
- Fax+1 (302) 655-5049
- Websitehttps://boundlessbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Milestone Pharmaceuticals Inc | 0.00 | -55.09m | 79.37m | 47.00 | -- | 1.99 | -- | -- | -1.25 | -1.25 | 0.00 | 0.7498 | 0.00 | -- | -- | 0.00 | -53.21 | -48.44 | -56.51 | -51.56 | -- | -- | -- | -1,267.25 | -- | -- | 0.5592 | -- | -80.00 | -- | -2.22 | -- | 86.23 | -- |
| Serina Therapeutics Inc | 137.00k | -20.96m | 79.85m | 4.00 | -- | -- | -- | 582.83 | -14.07 | -14.07 | 0.0909 | -0.5121 | 0.0117 | -- | 3.86 | 34,250.00 | -179.27 | -194.46 | -- | -- | 67.88 | 85.80 | -15,301.46 | -2,347.36 | -- | -0.9274 | 1.70 | -- | 317.65 | -36.69 | -41.49 | -- | -- | -- |
| Boundless Bio Inc | -100.00bn | -100.00bn | 80.12m | 72.00 | -- | -- | -- | -- | -- | -- | -- | 4.79 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -7.70 | -- | -- | -- |
| Maia Biotechnology Inc | 0.00 | -23.72m | 80.80m | 13.00 | -- | -- | -- | -- | -1.57 | -1.57 | 0.00 | -0.2801 | 0.00 | -- | -- | 0.00 | -266.70 | -- | -520.49 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -21.91 | -- | -- | -- |
| Cidara Therapeutics Inc | 46.38m | -36.47m | 80.80m | 69.00 | -- | -- | -- | 1.74 | -8.07 | -8.07 | 10.26 | -3.90 | 0.6899 | -- | 2.80 | 672,144.90 | -54.24 | -65.23 | -218.59 | -154.37 | 76.93 | -- | -78.63 | -100.61 | 0.6047 | -- | -- | -- | -0.8425 | -- | 31.72 | -- | 23.33 | -- |
| Chimerix Inc | 41.00k | -82.59m | 81.05m | 72.00 | -- | 0.4656 | -- | 1,976.89 | -0.9296 | -0.9296 | 0.0005 | 1.94 | 0.0002 | -- | 0.1226 | 569.44 | -36.50 | -30.45 | -39.59 | -34.09 | 100.00 | -- | -201,443.90 | -442.93 | -- | -- | 0.00 | -- | -99.04 | -46.24 | -147.68 | -- | -13.24 | -- |
| Ikena Oncology Inc | 3.85m | -70.09m | 81.07m | 34.00 | -- | 0.5219 | -- | 21.07 | -1.58 | -1.58 | 0.0861 | 3.22 | 0.0237 | -- | -- | 89,488.38 | -43.11 | -29.72 | -46.56 | -34.62 | -- | -- | -1,821.54 | -294.90 | -- | -- | 0.00 | -- | -41.35 | 56.05 | 0.8711 | -- | 6.30 | -- |
| AN2 Therapeutics Inc | 0.00 | -66.03m | 82.03m | 41.00 | -- | 0.7414 | -- | -- | -2.59 | -2.59 | 0.00 | 3.71 | 0.00 | -- | -- | 0.00 | -62.19 | -- | -68.38 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -51.33 | -- | -- | -- |
| Instil Bio Inc | 0.00 | -123.32m | 82.08m | 49.00 | -- | 0.3988 | -- | -- | -18.96 | -18.96 | 0.00 | 31.65 | 0.00 | -- | -- | 0.00 | -33.63 | -- | -35.47 | -- | -- | -- | -- | -- | -- | -- | 0.2841 | -- | -- | -- | 30.06 | -- | -- | -- |
| Kronos Bio Inc | 7.59m | -116.39m | 82.33m | 61.00 | -- | 0.601 | -- | 10.85 | -2.00 | -2.00 | 0.1301 | 2.28 | 0.0322 | -- | -- | 122,371.00 | -49.32 | -35.47 | -54.43 | -37.14 | -- | -- | -1,534.11 | -7,975.76 | -- | -- | 0.00 | -- | -- | -- | 15.41 | -- | -8.78 | -- |
| PMV Pharmaceuticals Inc | 0.00 | -65.10m | 82.82m | 63.00 | -- | 0.3894 | -- | -- | -1.32 | -1.32 | 0.00 | 4.13 | 0.00 | -- | -- | 0.00 | -26.53 | -21.16 | -27.81 | -21.91 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 5.94 | -- | 16.31 | -- |
| Sangamo Therapeutics Inc | 18.76m | -328.05m | 83.27m | 405.00 | -- | 1.44 | -- | 4.44 | -1.86 | -1.86 | 0.1057 | 0.2784 | 0.0659 | -- | 4.86 | 46,311.11 | -115.20 | -26.09 | -139.17 | -31.04 | -- | -- | -1,749.06 | -136.53 | -- | -- | 0.00 | -- | 58.34 | 15.85 | -34.09 | -- | -13.25 | -- |
| Bioatla Inc | 0.00 | -119.24m | 84.20m | 65.00 | -- | 1.69 | -- | -- | -2.49 | -2.49 | 0.00 | 1.03 | 0.00 | -- | -- | 0.00 | -81.18 | -48.72 | -96.07 | -57.35 | -- | -- | -- | -6,651.71 | -- | -- | 0.00 | -- | -- | -- | -15.95 | -- | -37.01 | -- |
Data as of Jul 23 2024. Currency figures normalised to Boundless Bio Inc's reporting currency: US Dollar USD
45.55%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 31 Mar 2024 | 3.26m | 14.66% |
| RA Capital Management LPas of 02 Apr 2024 | 2.18m | 9.80% |
| Redmile Group LLCas of 31 Mar 2024 | 1.11m | 5.01% |
| Sectoral Asset Management, Inc.as of 31 Mar 2024 | 855.88k | 3.85% |
| Citadel Advisors LLCas of 31 Mar 2024 | 853.53k | 3.84% |
| Wellington Management Co. LLPas of 02 Apr 2024 | 556.23k | 2.50% |
| Ensign Peak Advisors, Inc.as of 31 Mar 2024 | 375.00k | 1.69% |
| Federated Global Investment Management Corp.as of 31 Mar 2024 | 375.00k | 1.69% |
| SilverArc Capital Management LLCas of 31 Mar 2024 | 312.50k | 1.40% |
| Alyeska Investment Group LPas of 31 Mar 2024 | 250.00k | 1.12% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
